| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 17.37M | 29.47M | 28.68M | 21.53M | 17.36M |
| Gross Profit | 13.28M | 29.47M | 28.68M | 21.53M | 17.36M |
| EBITDA | 21.74M | 23.39M | 22.58M | 15.65M | 12.21M |
| Net Income | 17.89M | 16.74M | 20.25M | 5.37M | 12.63M |
Balance Sheet | |||||
| Total Assets | 203.75M | 208.21M | 203.70M | 208.50M | 218.74M |
| Cash, Cash Equivalents and Short-Term Investments | 3.22M | 2.66M | 807.31K | 3.84M | 83.78K |
| Total Debt | 25.20M | 46.80M | 45.00M | 55.60M | 60.00M |
| Total Liabilities | 32.21M | 53.11M | 51.26M | 60.84M | 65.24M |
| Stockholders Equity | 171.54M | 155.10M | 152.44M | 147.66M | 153.50M |
Cash Flow | |||||
| Free Cash Flow | 10.87M | 13.78M | 15.10M | 15.84M | -19.85M |
| Operating Cash Flow | 10.87M | 13.78M | 15.10M | 15.84M | -19.85M |
| Investing Cash Flow | 7.63M | -3.30M | 7.51M | -2.80M | -41.04M |
| Financing Cash Flow | -24.16M | -11.56M | -25.64M | -15.53M | 17.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ― | 9.53 | 10.84% | 8.30% | -25.90% | 4.97% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | $162.31M | 11.23 | 5.30% | 21.24% | -55.82% | -4.97% | |
59 Neutral | $407.35M | 19.71 | 7.50% | 9.31% | 41.12% | -40.68% | |
59 Neutral | $318.64M | 10.64 | 5.42% | 16.61% | -3.09% | 200.66% | |
59 Neutral | $104.22M | 12.10 | 6.46% | 14.03% | -34.92% | -132.22% | |
53 Neutral | $300.22M | -5.23 | -12.44% | 21.13% | -91.81% | 78.46% |
On January 22, 2026, ArrowMark Financial Corp. entered into a dealer manager agreement with ArrowMark Asset Management and UBS Securities to launch a transferable rights offering that commenced the same day, allowing shareholders of record as of January 22 to subscribe for up to 2,604,156 new common shares at a rate of one share for every three rights held, with provisions for over-subscription and a minimum allocation for smaller holders. The company also signed agreements with Equiniti Trust Company as subscription agent and EQ Fund Solutions as information agent, and set an expiration date of February 18, 2026 for the exercise of rights and related guaranteed delivery procedures, a capital-raising move that, if fully subscribed, would significantly expand its share count and provide additional funding for its investment activities, affecting existing shareholders through potential dilution alongside the opportunity to maintain or increase their ownership stakes.
The most recent analyst rating on (BANX) stock is a Buy with a $24.50 price target. To see the full list of analyst forecasts on ArrowMark Financial Corp. stock, see the BANX Stock Forecast page.
On December 18, 2025, ArrowMark Financial Corp. entered into a securities purchase agreement with investors for a registered direct public offering of 673,249 shares of its common stock at $22.28 per share, slightly above its then net asset value of $22.20, making the transaction accretive to existing shareholders. The offering, conducted under an effective shelf registration, generated approximately $15.0 million in gross proceeds, with the shares expected to be delivered on December 19, 2025, and the company indicated that the net proceeds will be invested in line with its existing investment strategy, potentially reinforcing its income-focused portfolio in regulatory capital securities of financial institutions.
The most recent analyst rating on (BANX) stock is a Hold with a $22.50 price target. To see the full list of analyst forecasts on ArrowMark Financial Corp. stock, see the BANX Stock Forecast page.
On December 15, 2025, ArrowMark Financial Corp. announced a distribution agreement with ALPS Distributors, Inc. to issue and sell up to $25 million of its common stock through an at-the-market equity offering program. The agreement includes a sub-placement agent arrangement with UBS Securities LLC. The company intends to use the proceeds in line with its investment policy, and sales will be made at market prices, potentially above the net asset value. This move is part of ArrowMark’s strategy to enhance its financial flexibility and investment capabilities, although it comes with associated risks typical of investment companies.
The most recent analyst rating on (BANX) stock is a Hold with a $22.50 price target. To see the full list of analyst forecasts on ArrowMark Financial Corp. stock, see the BANX Stock Forecast page.